Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

For Monotherapy, P2Y12 Inhibitor Bests Aspirin After PCI for ACS: Meta-analysis

News Daily News

For Monotherapy, P2Y12 Inhibitor Bests Aspirin After PCI for ACS: Meta-analysis

Yael L. Maxwell

August 14, 2025

Prompt TAVI Benefits Asymptomatic AS Patients Regardless of Guideline Indication

News Conference News NY Valves 2025

Prompt TAVI Benefits Asymptomatic AS Patients Regardless of Guideline Indication

June 27, 2025

‘Sobering’ Adverse Event Rate With Evoque Seen in Real-world Use

News Daily News

‘Sobering’ Adverse Event Rate With Evoque Seen in Real-world Use

Yael L. Maxwell

June 18, 2025

Valve Thrombosis in TTVR Not Uncommon: Meta-analysis

News Daily News

Valve Thrombosis in TTVR Not Uncommon: Meta-analysis

June 17, 2025

Fewer MACCE With P2Y12 Inhibitor vs Aspirin Monotherapy Over 5 Years

News Daily News

Fewer MACCE With P2Y12 Inhibitor vs Aspirin Monotherapy Over 5 Years

Yael L. Maxwell

June 09, 2025

Stroke Risk Higher With TAVI vs Surgery at 5 Years: UK TAVI

News Conference News EuroPCR 2025

Stroke Risk Higher With TAVI vs Surgery at 5 Years: UK TAVI

Michael O'Riordan

May 23, 2025

Paclitaxel or Sirolimus: New PAD Studies Shed Light on Choices

News Conference News CX Symposium 2025

Paclitaxel or Sirolimus: New PAD Studies Shed Light on Choices

April 23, 2025

COMPARE-TAVI 1: Myval Performs Well Against Sapien at 1 Year

News Daily News

COMPARE-TAVI 1: Myval Performs Well Against Sapien at 1 Year

April 11, 2025

More ALIGN-AR Data Bolster Potential for a Dedicated AR Device

News Conference News ACC 2025

More ALIGN-AR Data Bolster Potential for a Dedicated AR Device

Yael L. Maxwell

March 30, 2025

What’s in a Name: Is It Time to Choose Between TAVI and TAVR?

News Features

What’s in a Name: Is It Time to Choose Between TAVI and TAVR?

Yael L. Maxwell

March 27, 2025

Need for Rethink of Discharge Medications After LAA Closure? EMERGE

News Conference News CRT 2025

Need for Rethink of Discharge Medications After LAA Closure? EMERGE

March 12, 2025

AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years

News Conference News CRT 2025

AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years

March 10, 2025

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.